Cardinal Infrastructure Group enters the back half of May with two powerful tailwinds from this week: a decisive Q1 earnings beat and a same-day analyst target raise that nearly blew through the prior consensus.
The numbers from Q1 were hard to dismiss. EPS came in at $0.23, well ahead of the $0.17 estimate. Revenue hit $167.5 million versus a $126.6 million forecast — a 32% beat on the top line. Management followed through by lifting full-year 2026 sales guidance to a $675–$685 million range, above both the prior guidance of $665–$678 million and the Street's $672 million estimate. The stock rallied on the print, though it gave back 5.4% on May 12 — suggesting the bar was already partly priced in after a 25% run over the prior month. That said, the stock is still up 2% on the week and an extraordinary 136% year-to-date.
The analyst reaction was swift and unambiguous. Stifel's Brian Brophy raised his price target to $63 from $41 on May 13 — a 54% lift in a single move — while maintaining a Buy. This is the fourth consecutive target increase from Brophy since initiating coverage in January 2026, starting at $28 and climbing through $31, $38, and $41 before this week's step-change. DA Davidson also holds a Buy and has similarly ratcheted targets higher through the year. With the stock closing at $57.09, the new $63 Stifel target implies modest upside of around 10% from current levels. The analyst consensus return potential sits at -28%, but note that this figure may lag the very latest target update — once the $63 level is fully reflected, the picture narrows considerably. The unanimous Buy consensus from two covering analysts reflects a young coverage universe still orienting around a fast-moving growth story.
Short interest is a genuine signal for this stock, not a footnote. ORTEX estimates 15.5% of the free float is currently sold short — a meaningful level for a construction-and-engineering name — and that position has been building over the past two weeks. Shorts added approximately 6% to the position over the week ended May 12, and the ORTEX short score climbed to 66.9, the highest reading in the trailing 10-day window. The lending market is not yet tight: availability is running at 168% of estimated short interest, with cost to borrow near 1.1%. There is no sign of a squeeze in the borrow pool at present. The prior monthly peak in short interest came in early April, near 2 million shares, before the position was pared back — and it has since been rebuilt toward those levels as the stock rallied hard.
The institutional register tells a similar story of rapid accumulation in a young public company. FMR (Fidelity) reported a nearly 10.8% stake as of February, entering fresh. AllianceBernstein, Emerald Advisers, and Wasatch all appear to be building positions. Emerald added 179,000 shares in Q1 2026; Wasatch added 355,000. Insider activity is modest but consistent — director Ivy Zelman purchased $251,000 worth of stock at $36.33 in late March, adding to a cluster of director buys at $21 in December. No insider has sold. The most recent company filing at $21 and the stock now at $57 illustrates the pace of re-rating this name has undergone since listing.
With the next earnings event flagged for May 21 and short interest still elevated at 15.5% of float, the question heading into that release is whether the guidance beat was enough to shake out remaining shorts — or whether a new audience of skeptics, drawn in by the rapid valuation expansion, continues to rebuild the short side around a stock that has already moved aggressively.
See the live data behind this article on ORTEX.
Open CDNL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
